ADC THERAPEUTICS Trademark

Trademark Overview


On Thursday, November 5, 2020, a trademark application was filed for ADC THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ADC THERAPEUTICS trademark a serial number of 90301364. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, July 12, 2024. This trademark is owned by ADC Therapeutics SA. The ADC THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment...
adc therapeutics

General Information


Serial Number90301364
Word MarkADC THERAPEUTICS
Filing DateThursday, November 5, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, July 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements


Description of MarkThe mark consists of the letters "ADC" above the word "THERAPEUTICS". A wave element extends across the letter "A" to a shared edge of the letters "D" and "C".
Goods and ServicesPharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameADC Therapeutics SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEpalinges 1066
CH

Party NameADC Therapeutics SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEpalinges 1066
CH

Trademark Events


Event DateEvent Description
Monday, November 9, 2020NEW APPLICATION ENTERED
Wednesday, January 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 7, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, February 2, 2021ASSIGNED TO EXAMINER
Saturday, February 6, 2021NON-FINAL ACTION WRITTEN
Saturday, February 6, 2021NON-FINAL ACTION E-MAILED
Saturday, February 6, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 5, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 6, 2021FINAL REFUSAL WRITTEN
Wednesday, October 6, 2021FINAL REFUSAL E-MAILED
Wednesday, October 6, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 6, 2022EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, April 6, 2022JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, April 6, 2022EX PARTE APPEAL-INSTITUTED
Wednesday, April 6, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, April 7, 2022ASSIGNED TO LIE
Tuesday, April 12, 2022ASSIGNED TO LIE
Wednesday, April 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 20, 2022EXPARTE APPEAL TERMINATED
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 18, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 18, 2023SOU EXTENSION 1 FILED
Wednesday, January 18, 2023SOU EXTENSION 1 GRANTED
Friday, January 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 13, 2023SOU EXTENSION 2 FILED
Thursday, July 13, 2023SOU EXTENSION 2 GRANTED
Saturday, July 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 18, 2024DIVISIONAL REQUEST RECEIVED
Thursday, January 18, 2024SOU EXTENSION 3 FILED
Thursday, January 18, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 18, 2024TEAS REQUEST TO DIVIDE RECEIVED
Monday, February 5, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 26, 2024DIVISIONAL PROCESSING COMPLETE
Monday, February 26, 2024SOU EXTENSION 3 GRANTED
Tuesday, February 27, 2024CORRECTED NOA E-MAILED
Tuesday, February 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 12, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 12, 2024SOU EXTENSION 4 FILED
Friday, July 12, 2024SOU EXTENSION 4 GRANTED